Zusammenfassung
Für Patienten mit Morbus Parkinson sind Schmerzen ein häufiges Symptom, das ihre Lebensqualität stark beeinträchtigen kann. Die zugrunde liegende Pathophysiologie ist bisher nur wenig verstanden, ein Zusammenspiel aus Veränderungen im Bereich der Basalganglien sowie anderer ebenfalls von Neurodegeneration betroffener Areale des deszendierenden schmerzhemmenden Systems scheint hier von zentraler Bedeutung zu sein.
Literatur
Beiske AG, Loge JH, Ronningen A, Svensson E. Pain in Parkinson’s disease: Prevalence and characteristics. Pain. 2009 Jan;141(1-2):173–7.
Snider SR, Fahn S, Isgreen WP, Cote LJ. Primary sensory sympatoms in parkinsonism. Neurology. 1976 May;26(5):423–9.
Chaudhuri KR, Prieto-Jurcynska C, Naidu Y, Mitra T, Frades-Payo B, Tluk S, et al. The nondeclaration of nonmotor symptoms of Parkinson’s disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Movement disorders: official journal of the Movement Disorder Society. 2010 Apr 30;25(6):704–9.
Gallagher DA, Lees AJ, Schrag A. What are the most important nonmotor symptoms in patients with Parkinson’s disease and are we missing them? Movement disorders: official journal of the Movement Disorder Society. 2010 Nov 15;25(15):2493–500.
Politis M, Wu K, Molloy S, P GB, Chaudhuri KR, Piccini P. Parkinson’s disease symptoms: the patient’s perspective. Movement disorders: official journal of the Movement Disorder Society. 2010 Aug 15;25(11):1646–51.
Defazio G, Berardelli A, Fabbrini G, Martino D, Fincati E, Fiaschi A, et al. Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. Arch Neurol. 2008 Sep;65(9):1191–4.
Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006 May;10(4):287–333.
Zambito Marsala S, Tinazzi M, Vitaliani R, Recchia S, Fabris F, Marchini C, et al. Spontaneous pain, pain threshold, and pain tolerance in Parkinson’s disease. Journal of neurology. 2011 Apr;258(4):627–33.
Ehrt U, Larsen JP, Aarsland D. Pain and its relationship to depression in Parkinson disease. The American journal of geriatric psychiatry: official journal of the American Association for Geriatric Psychiatry. 2009 Apr;17(4):269–75.
Tinazzi M, Del Vesco C, Fincati E, Ottaviani S, Smania N, Moretto G, et al. Pain and motor complications in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2006 Jul;77(7):822–5.
Greenbaum L, Tegeder I, Barhum Y, Melamed E, Roditi Y, Djaldetti R. Contribution of genetic variants to pain susceptibility in Parkinson disease. European journal of pain. 2012 Oct;16(9):1243–50.
Riley D, Lang AE, Blair RD, Birnbaum A, Reid B. Frozen shoulder and other shoulder disturbances in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1989 Jan;52(1):63–6.
Pont-Sunyer C, Hotter A, Gaig C, Seppi K, Compta Y, Katzenschlager R, et al. The Onset of Nonmotor Symptoms in Parkinson’s disease (The ONSET PD Study). Movement disorders: official journal of the Movement Disorder Society. 2014 Dec 1.
Lin CH, Wu RM, Chang HY, Chiang YT, Lin HH. Preceding pain symptoms and Parkinson’s disease: a nationwide population-based cohort study. European journal of neurology: the official journal of the European Federation of Neurological Societies. 2013 Oct;20(10):1398–404.
van Wijk G, Veldhuijzen DS. Perspective on diffuse noxious inhibitory controls as a model of endogenous pain modulation in clinical pain syndromes. The journal of pain: official journal of the American Pain Society. 2010 May;11(5):408–19.
Chudler EH, Dong WK. The role of the basal ganglia in nociception and pain. Pain. 1995 Jan;60(1):3–38.
Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K. Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res. 2004 Oct;318(1):121–34.
Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging. 2003 Mar-Apr;24(2):197–211. Epub 2002/12/25. eng.
Nolano M, Provitera V, Estraneo A, Selim MM, Caporaso G, Stancanelli A, et al. Sensory deficit in Parkinson’s disease: evidence of a cutaneous denervation. Brain. 2008 Jul;131(Pt 7):1903–11.
Ford B. Pain in Parkinson’s disease. Movement disorders: official journal of the Movement Disorder Society. 2010;25 Suppl 1:S98–103.
Lee MA, Walker RW, Hildreth TJ, Prentice WM. A survey of pain in idiopathic Parkinson’s disease. J Pain Symptom Manage. 2006 Nov;32(5):462–9.
Negre-Pages L, Regragui W, Bouhassira D, Grandjean H, Rascol O. Chronic pain in Parkinson’s disease: the cross-sectional French DoPaMiP survey. Mov Disord. 2008 Jul 30;23(10):1361–9.
Wasner G, Deuschl G. Pains in Parkinson disease-many syndromes under one umbrella. Nature reviews Neurology. 2012 May;8(5):284–94.
Broetz D, Eichner M, Gasser T, Weller M, Steinbach JP. Radicular and nonradicular back pain in Parkinson’s disease: a controlled study. Movement disorders: official journal of the Movement Disorder Society. 2007 Apr 30;22(6):853–6.
Djaldetti R, Shifrin A, Rogowski Z, Sprecher E, Melamed E, Yarnitsky D. Quantitative measurement of pain sensation in patients with Parkinson disease. Neurology. 2004 Jun 22;62(12):2171–5.
Nebe A, Ebersbach G. Pain intensity on and off levodopa in patients with Parkinson’s disease. Mov Disord. 2009 Jun 15;24(8):1233–7.
Baron R. Pharmakologisch nicht interventionelle Therapie chronisch neuropathischer Schmerzen. In: Diener HC, Weimar, C. (Hrsg.), editor. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Thieme Verlag; 2012.
Author information
Authors and Affiliations
Corresponding author
Additional information
Interessenkonflikt
Die Autorin erklärt, dass sie sich bei der Erstellung des Beitrags von keinen wirtschaftlichen Interessen leiten ließ und erklärt Ihren Dank an die deutschen Parkinsonvereinigung dpv e. V. für die Unterstützung des Forschungsprojekts „Parkinson & Schmerz“. Werbung in dieser Zeitschriftenausgabe hat keinen Bezug zur CME-Fortbildung. Der Verlag garantiert, dass die CME-Fortbildung sowie die CME-Fragen frei sind von werblichen Aussagen und keinerlei Produktempfehlungen enthalten. Dies gilt insbesondere für Präparate, die zur Therapie des dargestellten Krankheitsbildes geeignet sind.
Rights and permissions
About this article
Cite this article
Grashorn, W. Aktuelle Strategien gegen Schmerzen bei Morbus Parkinson. InFo Neurologie 17, 44–52 (2015). https://doi.org/10.1007/s15005-015-1131-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15005-015-1131-4